eli lilly phase 3 trial retatrutide just announced striking results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide produces up to 30.3%

Trusted local, physician-supervised care Weve helped hundreds of South Florida residents successfully lose weight with GLP-1 medications

Anyone with a personal or family history of certain thyroid cancers should discuss this specifically with their prescribing physician before starting treatment

And if youre curious about microdosingAKA starting with the lowest effective dose to cut side effects and coststhese platforms make the process especially straightforward

Certified & licensed care Other conditions we treat

Enhances Insulin Sensitivity: GLP-1 improves insulin sensitivity, particularly in muscle tissue, allowing cells to utilize glucose more efficiently for energy rather than storing it as fat

NHS criteria havent been set because retatrutide isnt approved